Abstract
Cyclodextrins (CDs) offer a potential solution to delivery of hydrophobic drugs. Cyclodextrins are capable of hydrophobic drug binding due to their unique property of possessing a hydrophobic interior cavity and a hydrophilic exterior. When hydrophobic drugs are complexed with CD molecules a significant increase has been reported in the bioavailability of those drugs in free solution. The unique characteristics of cyclodextrins facilitate in development of a hydrogel for delivering drugs with varying degree of aqueous solubility. Further, the mechanical and chemical properties of hydrogels can act as an excellent system in delivery of hydrophobic drugs through their gel matrix.
Keywords: Bioavailability, cyclodextrin-functionalized hydrogels, hydrophobic drugs.
Current Drug Therapy
Title:Cyclodextrin-Functionalized Hydrogels: A Novel Drug Delivery System for the Delivery of Hydrophobic Drugs
Volume: 9 Issue: 2
Author(s): Shailesh Thirumaleshwar and Parthasarthi K. Kulkarni
Affiliation:
Keywords: Bioavailability, cyclodextrin-functionalized hydrogels, hydrophobic drugs.
Abstract: Cyclodextrins (CDs) offer a potential solution to delivery of hydrophobic drugs. Cyclodextrins are capable of hydrophobic drug binding due to their unique property of possessing a hydrophobic interior cavity and a hydrophilic exterior. When hydrophobic drugs are complexed with CD molecules a significant increase has been reported in the bioavailability of those drugs in free solution. The unique characteristics of cyclodextrins facilitate in development of a hydrogel for delivering drugs with varying degree of aqueous solubility. Further, the mechanical and chemical properties of hydrogels can act as an excellent system in delivery of hydrophobic drugs through their gel matrix.
Export Options
About this article
Cite this article as:
Thirumaleshwar Shailesh and K. Kulkarni Parthasarthi, Cyclodextrin-Functionalized Hydrogels: A Novel Drug Delivery System for the Delivery of Hydrophobic Drugs, Current Drug Therapy 2014; 9 (2) . https://dx.doi.org/10.2174/1574885509666141117215954
DOI https://dx.doi.org/10.2174/1574885509666141117215954 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial: Non-Communicable Diseases: Gender Differences in Therapy
Current Medicinal Chemistry Editorial [Hot Topic: Sexual Medicine Research -PDE5 Inhibitors and Beyond (Executive Editor: Allen D. Seftel)]
Current Pharmaceutical Design Betaxolol Hydrochloride Loaded Chitosan Nanoparticles for Ocular Delivery and their Anti-glaucoma Efficacy
Current Drug Delivery A Nested Case-Control Study of Serum Fasting Lipid Profiles in Pre- Eclamptic Primigravidas in Ile-Ife, Nigeria
Current Hypertension Reviews Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis
Current Neuropharmacology Potential Effect of Angiotensin II Receptor Blockade in Adipose Tissue and Bone
Current Pharmaceutical Design Non-glycemic Adverse Effects of Insulin
Current Diabetes Reviews Coagulation Factor XIIIA (F13A1): Novel Perspectives in Treatment and Pharmacogenetics
Current Pharmaceutical Design Development, Validation, and Application of a High-Performance Liquid Chromatography Method for the Analysis of Dissolution Samples of Telmisartan and Rosuvastatin Calcium Double-Layer Formulation
Current Pharmaceutical Analysis Biological Responses to Hydrogen Molecule and its Preventive Effects on Inflammatory Diseases
Current Pharmaceutical Design The Plasminogen Activation System Promotes Neurorepair in the Ischemic Brain
Current Drug Targets Imaging Subclinical Atherosclerosis: Where Do We Stand?
Current Cardiology Reviews Editorial (Thematic Issue: Targeting Phosphodiesterases (PDEs) for Treatment of CNS Diseases)
Current Pharmaceutical Design Cerebral Hypoperfusion During Carotid Artery Stenosis can Lead to Cognitive Deficits that may be Independent of White Matter Lesion Load
Current Neurovascular Research Right or Left - Enantioselective Catalysis. New Ni, Pd and Pt Phosphane Complexes with the Chiral 9-Phenyldeltacyclanyl Substituent
Current Organic Chemistry Association of High Levels of Spot Urine Protein with High Blood Pressure, Mean Arterial Pressure and Pulse Pressure with the Development of Diabetic Chronic Kidney Dysfunction or Failure among Diabetic Patients. Statistical Regression Modeling to Predict Diabetic Proteinuria
Current Diabetes Reviews Vascular Wall Shear Stress in Clinical Practice
Current Vascular Pharmacology Meet Our Editorial Board Member
Current Vascular Pharmacology The Effects of Glucagon-Like Peptide Type 1 (GLP-1) and its Analogues in Adipose Tissue: Is there a way to Thermogenesis?
Current Molecular Medicine Impact of Diabetes on Vasculature: Focus on Nervous System
Current Diabetes Reviews